The American Association of Psychedelics is a leading organization in the evolution of psychedelic healthcare bringing best practices to medical and mental health specialists.
Our vision is to bring evidenced based research, training, and services to the betterment of society.
Membership in the AAP is open to individuals or organizations directly or indirectly involved in advancing psychedelic medicine and research. This openness is a core part of the AAP’s platform. Being an inclusive, responsive, and globally-minded organization represents the AAP’s core beliefs that knowledge and change come from all walks of life.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Tennessee College of Medicine and the American Association of Psychedelics. The University of Tennessee College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
The University of Tennessee College of Medicine designates this live activity for a maximum of 18.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AAP was founded in 2021 with a mission to unite the world’s leading experts in the use of psychedelic medicine and to establish industry-spanning standards of ethics, care, and safety.
This program provides 18.75 contact hours through the University of Tennessee, College of Nursing. The University of Tennessee, College of Nursing is an accredited provider of nursing continuing professional development by American Nurses Credentialing Center’s Commission of Accreditation. The specific criteria for awarding contact hours for this include see *.
*Criteria for obtaining contact hours is determined by the lead Nurse Planner for the event and may include:
The establishment of science-backed industry guidelines for developing and deploying psychedelic medicines in safe and ethical ways.
Utilizing and sharing reliable, testable, and proven information to spread awareness and education regarding psychedelic medicine and its potential to reshape mental healthcare.
The belief that people from all walks of life can contribute to our understanding of psychedelics and psychedelic medicines.
Policy regarding psychedelic medicine should be driven by science, not politics, and should always be crafted in ways that most benefit the public.
May 18 - 22, 2023